TreeWAS – Variant ID: rs73084982

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.082	0.918	0.000
R29 Other symptoms and signs involving the nervous and musculoskeletal systems	0.033	0.967	0.000
R29.4 Clicking hip	0.024	0.976	0.000
R29.3 Abnormal posture	0.024	0.976	0.000
R29.2 Abnormal reflex	0.024	0.976	0.000
R29.1 Meningismus	0.024	0.976	0.000
R29.0 Tetany	0.024	0.976	0.000
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.017	0.983	0.000
I63.9 Cerebral infarction, unspecified	0.000	0.985	0.015
R26 Abnormalities of gait and mobility	0.014	0.986	0.000
R27 Other lack of coordination	0.014	0.986	0.000
R27.8 Other and unspecified lack of coordination	0.012	0.988	0.000
K80.1 Calculus of gallbladder with other cholecystitis	0.000	0.988	0.012
R29.6 Tendency to fall, not elsewhere classified	0.011	0.988	0.000
L90.5 Scar conditions and fibrosis of skin	0.011	0.989	0.000
R26.3 Immobility	0.011	0.989	0.000
R26.2 Difficulty in walking, not elsewhere classified	0.011	0.989	0.000
N80.0 Endometriosis of uterus	0.011	0.989	0.000
R26.0 Ataxic gait	0.011	0.989	0.000
R27.0 Ataxia, unspecified	0.011	0.989	0.000
R26.8 Other and unspecified abnormalities of gait and mobility	0.011	0.989	0.000
R26.1 Paralytic gait	0.010	0.989	0.000
A04.7 Enterocolitis due to Clostridium difficile	0.000	0.990	0.010
R25 Abnormal involuntary movements	0.009	0.991	0.000
A04.5 Campylobacter enteritis	0.000	0.992	0.008
L82 Seborrhoeic keratosis	0.008	0.992	0.000
A04 Other bacterial intestinal infections	0.000	0.992	0.008
R25.8 Other and unspecified abnormal involuntary movements	0.007	0.993	0.000
K80.0 Calculus of gallbladder with acute cholecystitis	0.000	0.993	0.007
R25.0 Abnormal head movements	0.007	0.993	0.000
R25.1 Tremor, unspecified	0.006	0.994	0.000
K80 Cholelithiasis	0.000	0.994	0.006
R25.3 Fasciculation	0.006	0.994	0.000
R25.2 Cramp and spasm	0.006	0.994	0.000
A04.9 Bacterial intestinal infection, unspecified	0.000	0.994	0.006
A04.6 Enteritis due to Yersinia enterocolitica	0.000	0.994	0.006
A04.4 Other intestinal Escherichia coli infections	0.000	0.994	0.006
A04.3 Enterohaemorrhagic Escherichia coli infection	0.000	0.994	0.006
A04.2 Enteroinvasive Escherichia coli infection	0.000	0.994	0.006
A04.1 Enterotoxigenic Escherichia coli infection	0.000	0.994	0.006
A04.0 Enteropathogenic Escherichia coli infection	0.000	0.994	0.006
N87.0 Mild cervical dysplasia	0.006	0.994	0.000
K80.4 Calculus of bile duct with cholecystitis	0.000	0.995	0.005
K80.8 Other cholelithiasis	0.000	0.995	0.005
S61.8 Open wound of other parts of wrist and hand	0.000	0.995	0.005
K80.3 Calculus of bile duct with cholangitis	0.000	0.995	0.005
C77.2 Intra-abdominal lymph nodes	0.000	0.995	0.005
K90.0 Coeliac disease	0.000	0.996	0.004
T51.0 Ethanol	0.000	0.996	0.004
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.996	0.004
Z92.6 Personal history of chemotherapy for neoplastic disease	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
D61.9 Aplastic anaemia, unspecified	0.000	0.996	0.004
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.000	0.996	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.996	0.004
A04.8 Other specified bacterial intestinal infections	0.000	0.996	0.004
T43.2 Other and unspecified antidepressants	0.000	0.996	0.004
L90 Atrophic disorders of skin	0.003	0.996	0.000
I63 Cerebral infarction	0.000	0.997	0.003
C15.9 Oesophagus, unspecified	0.000	0.997	0.003
C15.5 Lower third of oesophagus	0.000	0.997	0.003
L43.9 Lichen planus, unspecified	0.000	0.997	0.003
N35.9 Urethral stricture, unspecified	0.003	0.997	0.000
J36 Peritonsillar abscess	0.000	0.997	0.003
N80 Endometriosis	0.003	0.997	0.000
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.000	0.997	0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.997	0.003
A09 Diarrhoea and gastro-enteritis of presumed infectious origin	0.000	0.997	0.003
A00-A09 Intestinal infectious diseases	0.000	0.997	0.003
C15 Malignant neoplasm of oesophagus	0.000	0.997	0.003
N83.2 Other and unspecified ovarian cysts	0.003	0.997	0.000
D61 Other aplastic anaemias	0.000	0.997	0.003
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.003
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.003
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
D63.0 Anaemia in neoplastic disease	0.000	0.997	0.003
N80.1 Endometriosis of ovary	0.003	0.997	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
L90.9 Atrophic disorder of skin, unspecified	0.003	0.997	0.000
L90.8 Other atrophic disorders of skin	0.003	0.997	0.000
L90.6 Striae atrophicae	0.003	0.997	0.000
L90.4 Acrodermatitis chronica atrophicans	0.003	0.997	0.000
L90.3 Atrophoderma of Pasini and Pierini	0.003	0.997	0.000
L90.2 Anetoderma of Jadassohn-Pellizzari	0.003	0.997	0.000
L90.1 Anetoderma of Schweninger-Buzzi	0.003	0.997	0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.000	0.997	0.003
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.000	0.997	0.003
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
T39.1 4-Aminophenol derivatives	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
D63 Anaemia in chronic diseases classified elsewhere	0.000	0.997	0.003
N80.8 Other endometriosis	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.997	0.003
D62 Acute posthaemorrhagic anaemia	0.000	0.997	0.003
O63.0 Prolonged first stage (of labour)	0.003	0.997	0.000
T51 Toxic effect of alcohol	0.000	0.997	0.003
C15.4 Middle third of oesophagus	0.000	0.997	0.003
D03.3 Melanoma in situ of other and unspecified parts of face	0.000	0.997	0.003
M50.3 Other cervical disk degeneration	0.003	0.997	0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.000	0.997	0.002
N80.6 Endometriosis in cutaneous scar	0.002	0.997	0.000
N80.5 Endometriosis of intestine	0.002	0.997	0.000
N80.4 Endometriosis of rectovaginal septum and vagina	0.002	0.997	0.000
C18 Malignant neoplasm of colon	0.000	0.997	0.003
A09.9 Gastroenteritis and colitis of unspecified origin	0.000	0.997	0.003
T51.9 Alcohol, unspecified	0.000	0.997	0.003
N80.2 Endometriosis of Fallopian tube	0.002	0.997	0.000
R59.0 Localised enlarged lymph nodes	0.000	0.997	0.003
D60-D64 Aplastic and other anaemias	0.000	0.997	0.003
C15.8 Overlapping lesion of oesophagus	0.000	0.997	0.002
C15.3 Upper third of oesophagus	0.000	0.997	0.002
C15.2 Abdominal part of oesophagus	0.000	0.997	0.002
C15.1 Thoracic part of oesophagus	0.000	0.997	0.002
C15.0 Cervical part of oesophagus	0.000	0.997	0.002
C18.9 Colon, unspecified	0.000	0.997	0.003
A06 Amoebiasis	0.000	0.997	0.002
A05 Other bacterial foodborne intoxications	0.000	0.997	0.002
A03 Shigellosis	0.000	0.997	0.002
A01 Typhoid and paratyphoid fevers	0.000	0.997	0.002
A00 Cholera	0.000	0.997	0.002
C18.3 Hepatic flexure	0.000	0.997	0.002
D61.8 Other specified aplastic anaemias	0.000	0.997	0.002
D61.3 Idiopathic aplastic anaemia	0.000	0.997	0.002
D61.2 Aplastic anaemia due to other external agents	0.000	0.997	0.002
D61.1 Drug-induced aplastic anaemia	0.000	0.997	0.002
D61.0 Constitutional aplastic anaemia	0.000	0.997	0.002
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.002	0.997	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.000	0.998	0.002
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.000	0.998	0.002
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.000	0.998	0.002
K90 Intestinal malabsorption	0.000	0.998	0.002
C18.2 Ascending colon	0.000	0.998	0.002
C18.5 Splenic flexure	0.000	0.998	0.002
G25.8 Other specified extrapyramidal and movement disorders	0.000	0.998	0.002
A02 Other Salmonella infections	0.000	0.998	0.002
C18.0 Caecum	0.000	0.998	0.002
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
K61.0 Anal abscess	0.002	0.998	0.000
N80.9 Endometriosis, unspecified	0.000	0.998	0.002
A07 Other protozoal intestinal diseases	0.000	0.998	0.002
J38.1 Polyp of vocal cord and larynx	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
M23.51 Chronic instability of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.002	0.998	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.000	0.998	0.002
N80.3 Endometriosis of pelvic peritoneum	0.002	0.998	0.000
T50.8 Diagnostic agents	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.998	0.002
D63.1 Anaemia in other chronic diseases classified elsewhere	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.002
C18.6 Descending colon	0.000	0.998	0.002
T51.8 Other alcohols	0.000	0.998	0.002
T51.3 Fusel oil	0.000	0.998	0.002
T51.2 2-Propanol	0.000	0.998	0.002
T51.1 Methanol	0.000	0.998	0.002
C18.1 Appendix	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
J38.7 Other diseases of larynx	0.000	0.998	0.002
C16.0 Cardia	0.000	0.998	0.002
C18.8 Overlapping lesion of colon	0.000	0.998	0.002
C18.4 Transverse colon	0.000	0.998	0.002
I63.8 Other cerebral infarction	0.000	0.998	0.002
S61.9 Open wound of wrist and hand, part unspecified	0.000	0.998	0.002
T39.0 Salicylates	0.000	0.998	0.002
B07 Viral warts	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
K90.9 Intestinal malabsorption, unspecified	0.000	0.998	0.002
A00.9 Cholera, unspecified	0.000	0.998	0.002
A00.1 Cholera due to Vibrio cholerae 01, biovar el tor	0.000	0.998	0.002
A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae	0.000	0.998	0.002
A01.4 Paratyphoid fever, unspecified	0.000	0.998	0.002
A01.3 Paratyphoid fever C	0.000	0.998	0.002
A01.2 Paratyphoid fever B	0.000	0.998	0.002
A01.1 Paratyphoid fever A	0.000	0.998	0.002
A01.0 Typhoid fever	0.000	0.998	0.002
A03.9 Shigellosis, unspecified	0.000	0.998	0.002
A03.8 Other shigellosis	0.000	0.998	0.002
A03.3 Shigellosis due to Shigella sonnei	0.000	0.998	0.002
A03.2 Shigellosis due to Shigella boydii	0.000	0.998	0.002
A03.1 Shigellosis due to Shigella flexneri	0.000	0.998	0.002
A03.0 Shigellosis due to Shigella dysenteriae	0.000	0.998	0.002
A05.9 Bacterial foodborne intoxication, unspecified	0.000	0.998	0.002
A05.8 Other specified bacterial foodborne intoxications	0.000	0.998	0.002
A05.4 Foodborne Bacillus cereus intoxication	0.000	0.998	0.002
A05.3 Foodborne Vibrio parahaemolyticus intoxication	0.000	0.998	0.002
A05.2 Foodborne Clostridium perfringens [Clostridium welchii] intoxication	0.000	0.998	0.002
A05.1 Botulism	0.000	0.998	0.002
A05.0 Foodborne staphylococcal intoxication	0.000	0.998	0.002
A06.9 Amoebiasis, unspecified	0.000	0.998	0.002
A06.8 Amoebic infection of other sites	0.000	0.998	0.002
A06.7 Cutaneous amoebiasis	0.000	0.998	0.002
A06.6 Amoebic brain abscess	0.000	0.998	0.002
A06.5 Amoebic lung abscess	0.000	0.998	0.002
A06.4 Amoebic liver abscess	0.000	0.998	0.002
A06.3 Amoeboma of intestine	0.000	0.998	0.002
A06.2 Amoebic nondysenteric colitis	0.000	0.998	0.002
A06.1 Chronic intestinal amoebiasis	0.000	0.998	0.002
A06.0 Acute amoebic dysentery	0.000	0.998	0.002
K70.1 Alcoholic hepatitis	0.000	0.998	0.002
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.000	0.998	0.002
C77.0 Lymph nodes of head, face and neck	0.000	0.998	0.002
T42.4 Benzodiazepines	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
N35.8 Other urethral stricture	0.002	0.998	0.000
T42.1 Iminostilbenes	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
N35 Urethral stricture	0.002	0.998	0.000
K90.3 Pancreatic steatorrhoea	0.000	0.998	0.002
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.998	0.002
K90.1 Tropical sprue	0.000	0.998	0.002
C20 Malignant neoplasm of rectum	0.000	0.998	0.002
S61 Open wound of wrist and hand	0.000	0.998	0.002
K76.6 Portal hypertension	0.000	0.998	0.002
T42.0 Hydantoin derivatives	0.000	0.998	0.002
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.000	0.998	0.002
K70 Alcoholic liver disease	0.000	0.998	0.002
A02.9 Salmonella infection, unspecified	0.000	0.998	0.002
A02.8 Other specified Salmonella infections	0.000	0.998	0.002
A02.2 Localised Salmonella infections	0.000	0.998	0.002
A02.1 Salmonella septicaemia	0.000	0.998	0.002
C77.8 Lymph nodes of multiple regions	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.000	0.998	0.002
C77.3 Axillary and upper limb lymph nodes	0.000	0.998	0.002
K70.9 Alcoholic liver disease, unspecified	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
A07.9 Protozoal intestinal disease, unspecified	0.000	0.998	0.002
A07.8 Other specified protozoal intestinal diseases	0.000	0.998	0.002
A07.3 Isosporiasis	0.000	0.998	0.002
A07.2 Cryptosporidiosis	0.000	0.998	0.002
A07.0 Balantidiasis	0.000	0.998	0.002
C77.9 Lymph node, unspecified	0.000	0.998	0.002
C77.4 Inguinal and lower limb lymph nodes	0.000	0.998	0.002
K76.9 Liver disease, unspecified	0.000	0.998	0.002
M93.9 Osteochondropathy, unspecified	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
R59.1 Generalised enlarged lymph nodes	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
C77.5 Intrapelvic lymph nodes	0.000	0.998	0.002
K80.2 Calculus of gallbladder without cholecystitis	0.000	0.998	0.002
H21.5 Other adhesions and disruptions of iris and ciliary body	0.002	0.998	0.000
K70.3 Alcoholic cirrhosis of liver	0.000	0.998	0.002
C16 Malignant neoplasm of stomach	0.000	0.998	0.002
J38.4 Oedema of larynx	0.000	0.998	0.002
R82.9 Other and unspecified abnormal finding in urine	0.002	0.998	0.000
J38.0 Paralysis of vocal cords and larynx	0.000	0.998	0.002
K70.0 Alcoholic fatty liver	0.000	0.998	0.002
K90.8 Other intestinal malabsorption	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
A02.0 Salmonella gastro-enteritis	0.000	0.998	0.001
D60.9 Acquired pure red cell aplasia, unspecified	0.000	0.998	0.002
D60.8 Other acquired pure red cell aplasias	0.000	0.998	0.002
D60.1 Transient acquired pure red cell aplasia	0.000	0.998	0.002
D60.0 Chronic acquired pure red cell aplasia	0.000	0.998	0.002
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.998	0.002
H21.8 Other specified disorders of iris and ciliary body	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.002
T40.8 Lysergide [LSD]	0.000	0.998	0.002
T40.7 Cannabis (derivatives)	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.000	0.998	0.002
T40.5 Cocaine	0.000	0.998	0.002
T40.3 Methadone	0.000	0.998	0.002
T40.1 Heroin	0.000	0.998	0.002
T40.0 Opium	0.000	0.998	0.002
H21 Other disorders of iris and ciliary body	0.002	0.998	0.000
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.998	0.002
L43 Lichen planus	0.000	0.998	0.002
C15-C26 Malignant neoplasms of digestive organs	0.000	0.998	0.002
C77.1 Intrathoracic lymph nodes	0.000	0.998	0.002
O69.9 Labour and delivery complicated by cord complication, unspecified	0.002	0.998	0.000
S61.1 Open wound of finger(s) with damage to nail	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.001
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.001
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.001
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.001
T45.4 Iron and its compounds	0.000	0.998	0.001
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.001
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.001
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.001
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.001
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.001
T47.7 Emetics	0.000	0.998	0.001
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.001
T47.5 Digestants	0.000	0.998	0.001
T47.4 Other laxatives	0.000	0.998	0.001
T47.3 Saline and osmotic laxatives	0.000	0.998	0.001
T47.2 Stimulant laxatives	0.000	0.998	0.001
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.001
R59 Enlarged lymph nodes	0.000	0.998	0.002
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.998	0.002
N35.1 Postinfective urethral stricture, not elsewhere classified	0.002	0.998	0.000
N35.0 Posttraumatic urethral stricture	0.002	0.998	0.000
H18 Other disorders of cornea	0.002	0.998	0.000
A07.1 Giardiasis [lambliasis]	0.000	0.998	0.001
H18.1 Bullous keratopathy	0.002	0.998	0.000
J38.6 Stenosis of larynx	0.000	0.998	0.002
J38.5 Laryngeal spasm	0.000	0.998	0.002
J38.3 Other diseases of vocal cords	0.000	0.998	0.002
O69.2 Labour and delivery complicated by other cord entanglement	0.002	0.998	0.000
M24.16 Other articular cartilage disorders (Lower leg)	0.002	0.998	0.000
K70.4 Alcoholic hepatic failure	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.001
T45.5 Anticoagulants	0.000	0.998	0.001
H18.5 Hereditary corneal dystrophies	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.001
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.001
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.001
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.001
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.001
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.001
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.001
T44.0 Anticholinesterase agents	0.000	0.998	0.001
C21 Malignant neoplasm of anus and anal canal	0.000	0.998	0.002
N83.1 Corpus luteum cyst	0.002	0.998	0.000
A08 Viral and other specified intestinal infections	0.000	0.998	0.001
D64 Other anaemias	0.000	0.998	0.002
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)	0.002	0.998	0.000
J38.2 Nodules of vocal cords	0.000	0.998	0.002
L90.0 Lichen sclerosus et atrophicus	0.001	0.998	0.000
O69.1 Labour and delivery complicated by cord around neck, with compression	0.002	0.998	0.000
C16.8 Overlapping lesion of stomach	0.000	0.998	0.001
C16.6 Greater curvature of stomach, unspecified	0.000	0.998	0.001
C16.4 Pylorus	0.000	0.998	0.001
C16.3 Pyloric antrum	0.000	0.998	0.001
C16.2 Body of stomach	0.000	0.998	0.001
C16.1 Fundus of stomach	0.000	0.998	0.001
C21.1 Anal canal	0.000	0.998	0.001
C78.2 Secondary malignant neoplasm of pleura	0.000	0.998	0.002
S61.7 Multiple open wounds of wrist and hand	0.000	0.998	0.001
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.001
C26 Malignant neoplasm of other and ill-defined digestive organs	0.000	0.998	0.001
H18.8 Other specified disorders of cornea	0.001	0.998	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.998	0.002
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.998	0.002
C16.5 Lesser curvature of stomach, unspecified	0.000	0.998	0.001
H20.0 Acute and subacute iridocyclitis	0.001	0.998	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.001	0.998	0.000
H21.4 Pupillary membranes	0.001	0.998	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.001	0.998	0.000
H21.2 Degeneration of iris and ciliary body	0.001	0.998	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.001	0.998	0.000
H21.0 Hyphaema	0.001	0.998	0.000
N64.8 Other specified disorders of breast	0.002	0.998	0.000
U80.0 Penicillin resistant agent	0.000	0.998	0.002
O69 Labour and delivery complicated by umbilical cord complications	0.002	0.998	0.000
L43.8 Other lichen planus	0.000	0.998	0.001
L43.3 Subacute (active) lichen planus	0.000	0.998	0.001
L43.2 Lichenoid drug reaction	0.000	0.998	0.001
L43.1 Bullous lichen planus	0.000	0.998	0.001
L43.0 Hypertrophic lichen planus	0.000	0.998	0.001
R59.9 Enlarged lymph nodes, unspecified	0.000	0.998	0.001
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.001
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.001
K76 Other diseases of liver	0.000	0.998	0.002
H18.9 Disorder of cornea, unspecified	0.001	0.998	0.000
H18.7 Other corneal deformities	0.001	0.998	0.000
H18.6 Keratoconus	0.001	0.998	0.000
H18.3 Changes in corneal membranes	0.001	0.998	0.000
H18.2 Other corneal oedema	0.001	0.998	0.000
H18.0 Corneal pigmentations and deposits	0.001	0.998	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.002	0.998	0.000
H18.4 Corneal degeneration	0.001	0.998	0.000
K72.9 Hepatic failure, unspecified	0.000	0.998	0.001
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.001	0.999	0.000
H17 Corneal scars and opacities	0.001	0.999	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.000	0.999	0.001
C21.2 Cloacogenic zone	0.000	0.999	0.001
C26.0 Intestinal tract, part unspecified	0.000	0.999	0.001
H17.9 Corneal scar and opacity, unspecified	0.001	0.999	0.000
H20 Iridocyclitis	0.001	0.999	0.000
A08.5 Other specified intestinal infections	0.000	0.999	0.001
A08.3 Other viral enteritis	0.000	0.999	0.001
A08.2 Adenoviral enteritis	0.000	0.999	0.001
A08.0 Rotaviral enteritis	0.000	0.999	0.001
C16.9 Stomach, unspecified	0.000	0.999	0.001
D64.8 Other specified anaemias	0.000	0.999	0.001
D64.4 Congenital dyserythropoietic anaemia	0.000	0.999	0.001
D64.3 Other sideroblastic anaemias	0.000	0.999	0.001
D64.2 Secondary sideroblastic anaemia due to drugs and toxins	0.000	0.999	0.001
D64.1 Secondary sideroblastic anaemia due to disease	0.000	0.999	0.001
D64.0 Hereditary sideroblastic anaemia	0.000	0.999	0.001
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.999	0.001
Z74.0 Reduced mobility	0.000	0.999	0.001
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.000	0.999	0.001
C17 Malignant neoplasm of small intestine	0.000	0.999	0.001
M00.96 Pyogenic arthritis, unspecified (Lower leg)	0.001	0.999	0.000
C21.0 Anus, unspecified	0.000	0.999	0.001
C26.9 Ill-defined sites within the digestive system	0.000	0.999	0.001
C26.8 Overlapping lesion of digestive system	0.000	0.999	0.001
C26.1 Spleen	0.000	0.999	0.001
H20.1 Chronic iridocyclitis	0.001	0.999	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.001	0.999	0.000
H66.3 Other chronic suppurative otitis media	0.001	0.999	0.000
O69.5 Labour and delivery complicated by vascular lesion of cord	0.001	0.999	0.000
O69.4 Labour and delivery complicated by vasa praevia	0.001	0.999	0.000
O69.3 Labour and delivery complicated by short cord	0.001	0.999	0.000
O69.0 Labour and delivery complicated by prolapse of cord	0.001	0.999	0.000
Q54.9 Hypospadias, unspecified	0.001	0.999	0.000
K76.7 Hepatorenal syndrome	0.000	0.999	0.001
K76.5 Hepatic veno-occlusive disease	0.000	0.999	0.001
K76.4 Peliosis hepatis	0.000	0.999	0.001
K76.3 Infarction of liver	0.000	0.999	0.001
K76.2 Central haemorrhagic necrosis of liver	0.000	0.999	0.001
K76.1 Chronic passive congestion of liver	0.000	0.999	0.001
N90.7 Vulvar cyst	0.000	0.999	0.001
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.001	0.999	0.000
Z82.3 Family history of stroke	0.000	0.999	0.001
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.001	0.999	0.000
H15 Disorders of sclera	0.001	0.999	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.001	0.999	0.000
M54.16 Radiculopathy (Lumbar region)	0.001	0.999	0.000
H17.8 Other corneal scars and opacities	0.001	0.999	0.000
H17.1 Other central corneal opacity	0.001	0.999	0.000
H17.0 Adherent leukoma	0.001	0.999	0.000
L91.8 Other hypertrophic disorders of skin	0.001	0.999	0.000
M89.9 Disorder of bone, unspecified	0.001	0.999	0.000
O04.9 Complete or unspecified, without complication	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations